Annual CFI
$90.91 M
+$205.23 M+179.51%
December 31, 2023
Summary
- As of February 7, 2025, CORT annual cash flow from investing activities is $90.91 million, with the most recent change of +$205.23 million (+179.51%) on December 31, 2023.
- During the last 3 years, CORT annual CFI has risen by +$210.17 million (+176.22%).
- CORT annual CFI is now -33.22% below its all-time high of $136.13 million, reached on December 31, 2021.
Performance
CORT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$44.04 M
+$16.16 M+26.84%
September 30, 2024
Summary
- As of February 7, 2025, CORT quarterly cash flow from investing activities is -$44.04 million, with the most recent change of +$16.16 million (+26.84%) on September 30, 2024.
- Over the past year, CORT quarterly CFI has dropped by -$35.02 million (-388.53%).
- CORT quarterly CFI is now -121.22% below its all-time high of $207.47 million, reached on March 31, 2023.
Performance
CORT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$96.15 M
+$65.53 M+40.53%
September 30, 2024
Summary
- As of February 7, 2025, CORT TTM cash flow from investing activities is -$96.15 million, with the most recent change of +$65.53 million (+40.53%) on September 30, 2024.
- Over the past year, CORT TTM CFI has increased by +$29.44 million (+23.44%).
- CORT TTM CFI is now -159.59% below its all-time high of $161.35 million, reached on June 30, 2023.
Performance
CORT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CORT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +179.5% | -388.5% | +23.4% |
| 3 y3 years | +176.2% | -155.4% | +15.9% |
| 5 y5 years | +200.2% | -155.4% | +15.9% |
CORT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -33.2% | +179.5% | -121.2% | +59.8% | -159.6% | +40.5% |
| 5 y | 5-year | -33.2% | +176.2% | -121.2% | +59.8% | -159.6% | +50.0% |
| alltime | all time | -33.2% | +176.2% | -121.2% | +59.8% | -159.6% | +50.0% |
Corcept Therapeutics Incorporated Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$44.04 M(-26.8%) | -$96.15 M(-40.5%) |
| Jun 2024 | - | -$60.19 M(+567.8%) | -$161.68 M(+28.7%) |
| Mar 2024 | - | -$9.01 M(-152.7%) | -$125.58 M(-238.1%) |
| Dec 2023 | $90.91 M(-179.5%) | $17.10 M(-115.6%) | $90.91 M(+60.7%) |
| Sep 2023 | - | -$109.57 M(+354.7%) | $56.57 M(-64.9%) |
| Jun 2023 | - | -$24.10 M(-111.6%) | $161.35 M(+12.3%) |
| Mar 2023 | - | $207.47 M(-1303.4%) | $143.64 M(-225.6%) |
| Dec 2022 | -$114.33 M(-184.0%) | -$17.24 M(+259.9%) | -$114.33 M(-363.5%) |
| Sep 2022 | - | -$4.79 M(-88.5%) | $43.38 M(+93.9%) |
| Jun 2022 | - | -$41.80 M(-17.2%) | $22.37 M(-74.8%) |
| Mar 2022 | - | -$50.50 M(-135.9%) | $88.91 M(-34.7%) |
| Dec 2021 | $136.13 M(-214.1%) | $140.47 M(-644.4%) | $136.13 M(+1880.0%) |
| Sep 2021 | - | -$25.80 M(-204.3%) | $6.88 M(-121.8%) |
| Jun 2021 | - | $24.74 M(-853.4%) | -$31.59 M(-77.8%) |
| Mar 2021 | - | -$3.28 M(-129.3%) | -$142.28 M(+19.3%) |
| Dec 2020 | -$119.26 M(+1.2%) | $11.22 M(-117.5%) | -$119.26 M(-38.0%) |
| Sep 2020 | - | -$64.27 M(-25.2%) | -$192.47 M(+5.5%) |
| Jun 2020 | - | -$85.94 M(-535.5%) | -$182.51 M(+86.8%) |
| Mar 2020 | - | $19.73 M(-131.8%) | -$97.73 M(-17.1%) |
| Dec 2019 | -$117.83 M(+29.8%) | -$61.99 M(+14.1%) | -$117.83 M(+104.6%) |
| Sep 2019 | - | -$54.32 M(+4598.6%) | -$57.60 M(+56.6%) |
| Jun 2019 | - | -$1.16 M(+215.0%) | -$36.79 M(-35.3%) |
| Mar 2019 | - | -$367.00 K(-79.1%) | -$56.84 M(-37.4%) |
| Dec 2018 | -$90.77 M(+23.6%) | -$1.76 M(-94.8%) | -$90.77 M(-22.1%) |
| Sep 2018 | - | -$33.51 M(+58.0%) | -$116.46 M(+23.1%) |
| Jun 2018 | - | -$21.21 M(-38.1%) | -$94.60 M(+7.1%) |
| Mar 2018 | - | -$34.29 M(+24.9%) | -$88.34 M(+20.3%) |
| Dec 2017 | -$73.46 M(>+9900.0%) | -$27.45 M(+135.7%) | -$73.46 M(+59.4%) |
| Sep 2017 | - | -$11.65 M(-22.1%) | -$46.08 M(+33.5%) |
| Jun 2017 | - | -$14.95 M(-23.0%) | -$34.53 M(+76.3%) |
| Mar 2017 | - | -$19.41 M(>+9900.0%) | -$19.59 M(>+9900.0%) |
| Dec 2016 | -$194.00 K(+1041.2%) | -$75.00 K(-16.7%) | -$194.00 K(+90.2%) |
| Sep 2016 | - | -$90.00 K(+1185.7%) | -$102.00 K(+750.0%) |
| Jun 2016 | - | -$7000.00(-68.2%) | -$12.00 K(+140.0%) |
| Mar 2016 | - | -$22.00 K(-229.4%) | -$5000.00(-70.6%) |
| Dec 2015 | -$17.00 K(-90.2%) | $17.00 K(>+9900.0%) | -$17.00 K(-50.0%) |
| Sep 2015 | - | $0.00(0.0%) | -$34.00 K(-32.0%) |
| Jun 2015 | - | $0.00(-100.0%) | -$50.00 K(-49.0%) |
| Mar 2015 | - | -$34.00 K(<-9900.0%) | -$98.00 K(-43.7%) |
| Dec 2014 | -$174.00 K(+37.0%) | $0.00(-100.0%) | -$174.00 K(-18.7%) |
| Sep 2014 | - | -$16.00 K(-66.7%) | -$214.00 K(-18.6%) |
| Jun 2014 | - | -$48.00 K(-56.4%) | -$263.00 K(+20.1%) |
| Mar 2014 | - | -$110.00 K(+175.0%) | -$219.00 K(+72.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$127.00 K(-15.9%) | -$40.00 K(-38.5%) | -$127.00 K(-12.4%) |
| Sep 2013 | - | -$65.00 K(+1525.0%) | -$145.00 K(+9.8%) |
| Jun 2013 | - | -$4000.00(-77.8%) | -$132.00 K(-18.5%) |
| Mar 2013 | - | -$18.00 K(-69.0%) | -$162.00 K(+7.3%) |
| Dec 2012 | -$151.00 K(+504.0%) | -$58.00 K(+11.5%) | -$151.00 K(+28.0%) |
| Sep 2012 | - | -$52.00 K(+52.9%) | -$118.00 K(+78.8%) |
| Jun 2012 | - | -$34.00 K(+385.7%) | -$66.00 K(+106.3%) |
| Mar 2012 | - | -$7000.00(-72.0%) | -$32.00 K(+28.0%) |
| Dec 2011 | -$25.00 K(<-9900.0%) | -$25.00 K(<-9900.0%) | -$25.00 K(<-9900.0%) |
| Sep 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2010 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $0.00(0.0%) | $1.45 M(-59.7%) |
| Dec 2009 | $3.59 M(+54.3%) | $0.00(0.0%) | $3.59 M(-44.9%) |
| Sep 2009 | - | $0.00(-100.0%) | $6.53 M(<-9900.0%) |
| Jun 2009 | - | $1.45 M(-32.4%) | -$7000.00(-99.5%) |
| Mar 2009 | - | $2.14 M(-26.9%) | -$1.46 M(-162.6%) |
| Dec 2008 | $2.33 M(-143.3%) | $2.93 M(-144.9%) | $2.33 M(-151.6%) |
| Sep 2008 | - | -$6.53 M(<-9900.0%) | -$4.52 M(<-9900.0%) |
| Jun 2008 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2008 | - | $5.93 M(-251.5%) | $0.00(-100.0%) |
| Dec 2007 | -$5.38 M(-121.2%) | -$3.91 M(+94.1%) | -$5.38 M(-179.9%) |
| Sep 2007 | - | -$2.02 M(<-9900.0%) | $6.73 M(-50.8%) |
| Jun 2007 | - | $0.00(-100.0%) | $13.69 M(-37.5%) |
| Mar 2007 | - | $550.00 K(-93.3%) | $21.88 M(-13.7%) |
| Dec 2006 | $25.36 M(+67.9%) | $8.20 M(+65.9%) | $25.36 M(+8.7%) |
| Sep 2006 | - | $4.94 M(-39.8%) | $23.32 M(+14.8%) |
| Jun 2006 | - | $8.20 M(+103.6%) | $20.32 M(+28.2%) |
| Mar 2006 | - | $4.03 M(-34.6%) | $15.85 M(+4.9%) |
| Dec 2005 | $15.11 M(-138.2%) | $6.16 M(+217.7%) | $15.11 M(+308.7%) |
| Sep 2005 | - | $1.94 M(-48.0%) | $3.70 M(-126.4%) |
| Jun 2005 | - | $3.73 M(+13.4%) | -$14.01 M(-62.9%) |
| Mar 2005 | - | $3.29 M(-162.5%) | -$37.73 M(-4.5%) |
| Dec 2004 | -$39.51 M(-2513.2%) | -$5.25 M(-66.7%) | -$39.51 M(+31.4%) |
| Sep 2004 | - | -$15.77 M(-21.1%) | -$30.07 M(+236.6%) |
| Jun 2004 | - | -$19.99 M(-1428.4%) | -$8.93 M(-191.9%) |
| Mar 2004 | - | $1.50 M(-64.0%) | $9.72 M(+493.7%) |
| Dec 2003 | $1.64 M | $4.19 M(-22.0%) | $1.64 M(-164.3%) |
| Sep 2003 | - | $5.37 M(-501.6%) | -$2.55 M(-67.8%) |
| Jun 2003 | - | -$1.34 M(-79.7%) | -$7.92 M(+20.3%) |
| Mar 2003 | - | -$6.58 M | -$6.58 M |
FAQ
- What is Corcept Therapeutics Incorporated annual cash flow from investing activities?
- What is the all time high annual CFI for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual CFI year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly CFI year-on-year change?
- What is Corcept Therapeutics Incorporated TTM cash flow from investing activities?
- What is the all time high TTM CFI for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM CFI year-on-year change?
What is Corcept Therapeutics Incorporated annual cash flow from investing activities?
The current annual CFI of CORT is $90.91 M
What is the all time high annual CFI for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash flow from investing activities is $136.13 M
What is Corcept Therapeutics Incorporated annual CFI year-on-year change?
Over the past year, CORT annual cash flow from investing activities has changed by +$205.23 M (+179.51%)
What is Corcept Therapeutics Incorporated quarterly cash flow from investing activities?
The current quarterly CFI of CORT is -$44.04 M
What is the all time high quarterly CFI for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash flow from investing activities is $207.47 M
What is Corcept Therapeutics Incorporated quarterly CFI year-on-year change?
Over the past year, CORT quarterly cash flow from investing activities has changed by -$35.02 M (-388.53%)
What is Corcept Therapeutics Incorporated TTM cash flow from investing activities?
The current TTM CFI of CORT is -$96.15 M
What is the all time high TTM CFI for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM cash flow from investing activities is $161.35 M
What is Corcept Therapeutics Incorporated TTM CFI year-on-year change?
Over the past year, CORT TTM cash flow from investing activities has changed by +$29.44 M (+23.44%)